key: cord-1018582-es4pu5ki authors: Giudice, Amerigo; Antonelli, Alessandro; Bennardo, Francesco title: To test or not to test? An opportunity to restart dentistry sustainably in “COVID‐19 era” date: 2020-05-06 journal: Int Endod J DOI: 10.1111/iej.13324 sha: 5bfe8c64e0a5ad55c934e5c3339abda64cfee554 doc_id: 1018582 cord_uid: es4pu5ki COVID‐19, which appeared to originate in China in December 2019, has spread worldwide pandemically. Recently, a letter regarding COVID‐19 impact on dentistry has been published in this Journal (Prati et al. 2020). In Europe, Italy is the second most affected nation by COVID‐19 infection and the first for number of deaths (WHO SR). In March 2020, the Italian Ministry of Health ordered the suspension of all non‐urgent outpatient activities (including dentistry) in hospitals and clinics of the public health system, until the end of the lockdown (Press releases Italian Ministry of Health, 1). 4. healed after COVID-19. Despite double-phase triage may help in detecting potentially infected patients, asymptomatic SARS-CoV-2 positive patients are the most difficult to detect. The only way to spot patients is to test them. The tests to detect SARS-CoV-2 infection are of two types (WHO LT): 1. detection of genetic material of the virus (ribonucleic acid; RNA); 2. SARS-CoV-2-specific antibody detection (IgM, IgG). The gold standard test involves direct virus detection in the respiratory tract through a pharyngeal swab: nasopharynx (more sensitive) and/or oropharynx. The swab must be collected by a qualified healthcare professional. The sample is processed for the detection of the virus RNA through amplification with reverse transcriptase-polymerase chain reaction (RT-PCR). This test is accurate for the acute illness but is deeply influenced by sample collection and processing (INSERIRE Both tests must be processed in specialized laboratory processing. Other limitations are cost and time. Recently, rapid test for SARS-CoV-2 IgG-IgM combined antibody test using lateral flow immune assay techniques have been developed. These tests can detect IgM and IgG antibodies simultaneously against SARS-CoV-2 virus in human blood within 15 minutes which can detect patients at different infection stages (Li et al. 2020 ). This article is protected by copyright. All rights reserved The possibility of testing patients for SARS-CoV-2 prior to access to dental offices was not considered. Patients who are scheduled to be admitted to dental clinics always be assumed to be potential carriers of the virus even if they pass the pre-assessment triage. They may be screened with the gold standard swab RT-PCR test 24 hours before the treatment as well as with SARS-CoV-2-specific IgM/IgG detection. This screening may be useful to identify asymptomatic SARS-CoV-2 positive patient. Various scenario are described in Table 1 . In case of detection of SARS-CoV-2 RNA in the swab collected, patient must be referred to public health service for COVID-19 treatment protocol. In case of negative swab, the antibody test could help in classifying the patient among the categories healthy, healed, sick. A patient with negative swab, and IgM -and IgG+ is potentially healed and may undergo routine dental treatments. If patients show both negative results (swab and antibodies), they may complete dental emergency treatment, but need to redo tests in case of new admission. However, negative results of these tests (carried out correctly) do not exclude the possibility that patients are infected but in a windows period. In the COVID-19 era, situations rapidly change, and we all are facing something not experienced before. The absence of epidemiological investigations with tests in the second phase with eased restrictions could have severe consequences. At this stage many patients will need non-emergency dental treatment in order to avoid emergencies. Tests can be a strong tool to mitigate risks for patients and healthcare workers too. Great attention and rapid research should be done to validate rapid serological tests. They are cheap and fast and can be done anywhere, with results within few minutes. Testing is important to detect people with mild or no symptoms in order to stop infections in the community. On one side that can be a great chance for private health to complement public health, and on the other an opportunity to restart soon dentistry in a sustainably way. COVID-19. Nature Medicine. 2020. https://doi.org/10.1038/s41591-020-0897-1 -Prati, C., Pelliccioni, G. A., Sambri, V., Chersoni, S., & Gandolfi, M. G. (2020). COVID-19: its impact on dental schools in Italy, clinical problems in endodontic therapy and general considerations. International Endodontic Journal, 53 (5) This article is protected by copyright. All rights reserved [3] probable healed patient may undergo routine dental treatments [4] healthy patient may complete dental emergency treatment, but need to redo tests in case of new admission Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis Accepted Article